Desh Rakshak Aushdhalaya Limited (BOM:531521)
26.90
0.00 (0.00%)
At close: Aug 14, 2026
Desh Rakshak Aushdhalaya Revenue
Desh Rakshak Aushdhalaya had revenue of 8.28M INR in the quarter ending June 30, 2026, a decrease of -36.28%. This brings the company's revenue in the last twelve months to 66.33M, up 2.23% year-over-year. In the fiscal year ending March 31, 2026, Desh Rakshak Aushdhalaya had annual revenue of 71.04M with 13.30% growth.
Revenue (ttm)
66.33M
Revenue Growth
+2.23%
P/S Ratio
2.31
Revenue / Employee
3.32M
Employees
20
Market Cap
153.28M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 71.04M | 8.34M | 13.30% |
| Mar 31, 2025 | 62.71M | 2.63M | 4.37% |
| Mar 31, 2024 | 60.08M | -1.72M | -2.79% |
| Mar 31, 2023 | 61.80M | -91.20K | -0.15% |
| Mar 31, 2022 | 61.89M | -4.09M | -6.19% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Add-Shop E-Retail | 1.71B |
| Beryl Drugs | 215.51M |
| Unjha Formulations | 152.79M |
| Zenith Healthcare | 107.48M |
| Hamps Bio | 84.75M |
| Norris Medicines | 75.77M |
| Colinz Laboratories | 58.11M |
| Emmessar Biotech & Nutrition | 23.78M |